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Current Debate on Ethics in HTA
Why is ethics necessary in HTA? HTA represents a bridge 
between the scientific world (of research) and the political world 
(of decisions). When a decision must be made, we have to deal 
with questions that are not only qualitative (technical) but also 
quantitative (meaning and value). In technology, we can find 
answers regarding safety, effectiveness, efficiency and economic 
impact (quantitative questions), but not answers to ethical 
questions (qualitative questions). For example: Does the technology 
in question respect human’s life? Does it improve the patient’s 
quality of life? Is it accessible to everyone in the health system?
If ethics evaluation is central in a HTA, how can it be integrated 
in this process? According to some authors, this integration is not 
easy because of the epistemological difference between ethical 
domain and other domains of HTA [4]. In fact, an ethical analysis 
 
does not produce scientific evidence but uses the evidence reported 
by the other disciplines to highlight the moral issues and make an 
evaluation. Hofmann et al. identify four ways of integration: 
a) Submission (ethics assessment is a subsidiary activity, a 
sub-project of an HTA); 
b) Combination (ethics assessment is a separate activity); 
c) Coordination (ethics assessment is a separate part or 
process in HTA, but its role and importance may vary depending 
on the context); 
d) Interaction (ethics assessment influences, is influenced 
by, re-defines and is re-defined by other parts and elements of 
HTA) [5]. 
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Abstract
A trend or a useful tool? HTA (Health Technology Assessment) was born in the 70s as a tool to support decision makers in the health sector and has 
been quickly developing since, also with the creation of specialized international agencies (e.g. Health Technology Assessment International – HTAi; 
International Network of Assessment Agencies of health technologies - INAHTA). What is HTA? It is the “systematic evaluation of the properties and 
effects of a health technology, which addresses the direct and expected effects of this technology, as well as its indirect and unintended consequences, 
and aims primarily to inform decision-makers on health technologies” [1]. 
The approach is interdisciplinary, because HTA summarizes information on medical, social, economic and ethical issues, and methods of 
evaluation can be different [2]. Since of its born, ethics has been considered a key element in HTA, even if there is still not an agreement on “why” 
and “how” ethics should be integrated in HTA. This difficulty is not new and it mainly due to the narrowing of HTA to economic analysis. In 2004, ten 
Have has listed some potential reasons of this situation: 
a) Existing approaches for ethical inquiry are not suitable for HTA; 
b) Technologies are often considered by HTA producers as being value-free; 
c) The only questions perceived as relevant in an HTA are technical and economical ones; 
d) Value issues may be acknowledged to be present at all levels in HTA, but ethics is not needed to address these issues; 
e) It is practically difficult to integrate ethical considerations in HTA; 
f) HTA experts are not trained to make ethical assessments and there is too little expertise on ethics and HTA; g. Limited resources available to 
conduct ethical analyses [3].
Abbreviations: HTA: Health Technology Assessment; HTAI: Health Technology Assessment International; INAHTA: International Network of 
Assessment Agencies of Health Technologies 
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Other authors believe that it is not possible to separate ethics 
from a human choice. In fact, every free and voluntary act involves 
a moral question (licit / illicit, good / bad). As a result, ethics cannot 
be “integrated” into HTA because ethics is already a constitutive 
part of HTA. However, ethics can be recognized and emphasized [6]. 
The issue is not the expansion of HTA, to include ethics or integrate 
ethics into HTA [7], but to acknowledge that the use of any health 
technology will inevitably raise questions of meaning and value. 
HTA’s mission is to maximize population’s health and influence 
decision-making, taking into account and promoting equity and 
values and therefore also all the value judgments involved in the 
evaluations [8]. Therefore, it becomes necessary define the ethical 
approach in HTA assessment. Unlike the other fields of an HTA 
process, which are based on standardized methods of analysis, the 
ethical analysis is influenced by the ethical choice and the method 
of analysis. 
There are different methods, theories and positions that can 
be used to analyse ethical problems in HTA (e.g. Utilitarianism, 
Deontology, Casuistry, Principlism, Discourse Ethics, Wide 
Reflective Equilibrium) [9-11]. In addition to this, some ethics 
approaches, and methods have been developed and used especially 
for HTA (e.g. Socratic Approach; Social Shaping of Technology; 
Constructive Technology Assessment; Ethical Matrix; Interactive 
Health Technology Assessment) [5]. Furthermore, ethical analysis 
can be conducted in a descriptive or normative way. The descriptive 
way provides a list of ethical issues, which have to be identified, 
described and addressed (the most used modality); the normative 
way provides a moral judgment (e.g., the use of a technology is 
morally good/bad or ethically licit illicit) [12].
As a Proposal
Among normative models, our School uses the Triangular 
model [13]. The Triangular model, also known as the ‘‘personalist 
model’’, is rooted on the human person (body-soul unitotality) as 
reference-value in the reality, according the Aristotelian-Thomistic 
view. This approach includes factual, anthropological and ethical 
data in a ‘‘triangular’’ normative reflection process. The three steps 
of ethical process are: 
a) Data collection (knowledge level): an in-depth study of 
factual data concerning the object of the analysis; 
b) Ethical/anthropological analysis (justifying level) 
according to the following principles criteria: 
 i.   The defense of human physical life; 
ii. The therapeutic principle, according to which the human 
person has to be treated as a totality of body and soul;
iii. The interconnection between personal freedom and respon-
sibility; 
iv.  The principles of sociality and subsidiarity, for which public/
private bodies are called to help all persons, namely when they 
are not able to fulfil their needs; 
c) Appraisal (normative) level, that should establish if 
implementing a certain technology is ethically licit/illicit, and, 
therefore, facilitate practical choices [14].
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